Resumo

ERASO G, Ruth et al. Anti tumor necrosis factor therapy in Juvenile idiopathic arthritis. Rev.Colomb.Reumatol. [online]. 2006, vol.13, n.2, pp.154-168. ISSN 0121-8123.

From benefits observed in adults suffering rheumatoid arthritis treated with antagonists of tumoral necrosis factor, there was a growing interest about its use in children. However several conditions pertaining to pediatric rheumatology determine that available evidence be poor or of low quality. As a result of a critical review of the literature and after a consensus meeting a Practical Clinical Guide is presented: its purpose consist in offering recommendations for the rational use of these medications.

Palavras-chave : pediatric rheumatology; children; juvenile idiopathic arthritis; juvenile rheumatoid arthritis; tumor necrosis factor antagonists; etanercept; infliximab; adalimumab; efficacy; indications; doses; security; adverse effects.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )